CLINICAL_TRIALS
trial_result
· 2026-01-22
Clinical Trial Update: The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy [NA]
Summary
This clinical trial update notes a randomized controlled study evaluating Shenqi Yishen Granules for IgA nephropathy, with the trial not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Keda Lu | Conditions: IgA Nephropathy (IgAN) | NA | Status: NOT_YET_RECRUITING